ScienceMed®

Management of hidradenitis suppurativa in the inpatient setting: a clinical guide

Dermatologia
Imagem de arquivo, ilustrativa — não é do estudo. Epiderme e derme humanas ao microscópio óptico, coloração HE. Kilbad · domínio público · Wikimedia Commons

Diretriz clínicaNível 1 · Evidência consolidadaArchives of dermatological research8 jan 20258 citações

Salvar

Resumo original em inglês

O que aconteceu

Hidradenitis suppurativa (HS) is a chronic inflammatory disease that affects the axilla, inframammary folds, buttocks, inner thighs, and anogenital regions. Patients with moderate to severe HS often seek care in the emergency department and may require hospitalization; however, the lack of clear admission criteria and management guidelines presents significant challenges. To address these issues, we conducted a clinical review aimed at hospitalists and consulting dermatologists considering hospital admission for patients experiencing severe HS flares. Admission offers a unique opportunity to optimize care through specialized consultations, pain management, rescue therapy, and surgical planning. Furthermore, multimodal treatments, particularly biologics, are needed to achieve clinical remission in severe disease. Streamlining care during hospitalization for the early initiation of these therapies can significantly improve flare management and overall clinical outcomes for HS patients. This review aims to improve care for HS by providing clear and comprehensive guidance on its management in the inpatient setting.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Management of hidradenitis suppurativa in the inpatient setting: a clinical guide

Narges Maskan Bermudez, Scott A Elman, Robert S Kirsner, Hadar Lev-Tov

Descritores MeSH

  • Hospitalization
  • Hidradenitis Suppurativa
  • Pain Management
  • Humans
  • Severity of Illness Index

Veja também